nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Betamethasone—multiple sclerosis	0.469	0.632	CbGbCtD
Carbimazole—CYP19A1—Dexamethasone—multiple sclerosis	0.273	0.368	CbGbCtD
Carbimazole—Myopathy—Methylprednisolone—multiple sclerosis	0.0025	0.00997	CcSEcCtD
Carbimazole—Leukopenia—Fingolimod—multiple sclerosis	0.00245	0.00975	CcSEcCtD
Carbimazole—Throat sore—Triamcinolone—multiple sclerosis	0.00244	0.00972	CcSEcCtD
Carbimazole—Oropharyngeal discomfort—Triamcinolone—multiple sclerosis	0.00242	0.00963	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00231	0.00921	CcSEcCtD
Carbimazole—Myopathy—Betamethasone—multiple sclerosis	0.00227	0.00907	CcSEcCtD
Carbimazole—Myopathy—Dexamethasone—multiple sclerosis	0.00227	0.00907	CcSEcCtD
Carbimazole—Infection—Fingolimod—multiple sclerosis	0.00222	0.00883	CcSEcCtD
Carbimazole—Eosinophilia—Cladribine—multiple sclerosis	0.0022	0.00878	CcSEcCtD
Carbimazole—Nervous system disorder—Fingolimod—multiple sclerosis	0.00219	0.00872	CcSEcCtD
Carbimazole—Skin disorder—Fingolimod—multiple sclerosis	0.00217	0.00864	CcSEcCtD
Carbimazole—Pancytopenia—Cladribine—multiple sclerosis	0.00211	0.00842	CcSEcCtD
Carbimazole—Neutropenia—Cladribine—multiple sclerosis	0.00208	0.00829	CcSEcCtD
Carbimazole—Myopathy—Prednisone—multiple sclerosis	0.00198	0.0079	CcSEcCtD
Carbimazole—Oropharyngeal pain—Triamcinolone—multiple sclerosis	0.00193	0.00771	CcSEcCtD
Carbimazole—Contusion—Betamethasone—multiple sclerosis	0.00183	0.00729	CcSEcCtD
Carbimazole—Contusion—Dexamethasone—multiple sclerosis	0.00183	0.00729	CcSEcCtD
Carbimazole—Haemoglobin—Cladribine—multiple sclerosis	0.00179	0.00713	CcSEcCtD
Carbimazole—Haemorrhage—Cladribine—multiple sclerosis	0.00178	0.0071	CcSEcCtD
Carbimazole—Bone marrow depression—Methotrexate—multiple sclerosis	0.00172	0.00685	CcSEcCtD
Carbimazole—Pancytopenia—Azathioprine—multiple sclerosis	0.00172	0.00685	CcSEcCtD
Carbimazole—Liver disorder—Methotrexate—multiple sclerosis	0.0017	0.00679	CcSEcCtD
Carbimazole—Angiopathy—Cladribine—multiple sclerosis	0.00162	0.00644	CcSEcCtD
Carbimazole—Contusion—Prednisone—multiple sclerosis	0.00159	0.00635	CcSEcCtD
Carbimazole—Pruritus—Fingolimod—multiple sclerosis	0.00158	0.00629	CcSEcCtD
Carbimazole—Alopecia—Cladribine—multiple sclerosis	0.00157	0.00627	CcSEcCtD
Carbimazole—Agranulocytosis—Azathioprine—multiple sclerosis	0.0015	0.006	CcSEcCtD
Carbimazole—Haemoglobin—Azathioprine—multiple sclerosis	0.00145	0.0058	CcSEcCtD
Carbimazole—Haemorrhage—Azathioprine—multiple sclerosis	0.00145	0.00577	CcSEcCtD
Carbimazole—Ill-defined disorder—Cladribine—multiple sclerosis	0.00144	0.00573	CcSEcCtD
Carbimazole—Headache—Fingolimod—multiple sclerosis	0.0014	0.00557	CcSEcCtD
Carbimazole—Malaise—Cladribine—multiple sclerosis	0.0014	0.00557	CcSEcCtD
Carbimazole—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00139	0.00553	CcSEcCtD
Carbimazole—Neutropenia—Mitoxantrone—multiple sclerosis	0.00137	0.00545	CcSEcCtD
Carbimazole—Myalgia—Cladribine—multiple sclerosis	0.00132	0.00526	CcSEcCtD
Carbimazole—Arthralgia—Cladribine—multiple sclerosis	0.00132	0.00526	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00131	0.00522	CcSEcCtD
Carbimazole—Discomfort—Cladribine—multiple sclerosis	0.0013	0.0052	CcSEcCtD
Carbimazole—Alopecia—Azathioprine—multiple sclerosis	0.00128	0.0051	CcSEcCtD
Carbimazole—Jaundice—Mitoxantrone—multiple sclerosis	0.00127	0.00506	CcSEcCtD
Carbimazole—Stomatitis—Mitoxantrone—multiple sclerosis	0.00127	0.00506	CcSEcCtD
Carbimazole—Infection—Cladribine—multiple sclerosis	0.00126	0.00501	CcSEcCtD
Carbimazole—Nervous system disorder—Cladribine—multiple sclerosis	0.00124	0.00494	CcSEcCtD
Carbimazole—Thrombocytopenia—Cladribine—multiple sclerosis	0.00124	0.00494	CcSEcCtD
Carbimazole—Skin disorder—Cladribine—multiple sclerosis	0.00123	0.0049	CcSEcCtD
Carbimazole—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00122	0.00485	CcSEcCtD
Carbimazole—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00118	0.00469	CcSEcCtD
Carbimazole—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00117	0.00466	CcSEcCtD
Carbimazole—Hepatitis—Mitoxantrone—multiple sclerosis	0.00117	0.00466	CcSEcCtD
Carbimazole—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00117	0.00466	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00115	0.00459	CcSEcCtD
Carbimazole—Malaise—Azathioprine—multiple sclerosis	0.00114	0.00453	CcSEcCtD
Carbimazole—Leukopenia—Azathioprine—multiple sclerosis	0.00113	0.0045	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00109	0.00434	CcSEcCtD
Carbimazole—Arthralgia—Azathioprine—multiple sclerosis	0.00107	0.00428	CcSEcCtD
Carbimazole—Myalgia—Azathioprine—multiple sclerosis	0.00107	0.00428	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00107	0.00425	CcSEcCtD
Carbimazole—Discomfort—Azathioprine—multiple sclerosis	0.00106	0.00422	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—multiple sclerosis	0.00105	0.00418	CcSEcCtD
Carbimazole—Feeling abnormal—Cladribine—multiple sclerosis	0.00104	0.00415	CcSEcCtD
Carbimazole—Alopecia—Mitoxantrone—multiple sclerosis	0.00103	0.00412	CcSEcCtD
Carbimazole—Infection—Azathioprine—multiple sclerosis	0.00102	0.00407	CcSEcCtD
Carbimazole—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00101	0.00401	CcSEcCtD
Carbimazole—Urticaria—Cladribine—multiple sclerosis	0.001	0.004	CcSEcCtD
Carbimazole—Body temperature increased—Cladribine—multiple sclerosis	0.001	0.00399	CcSEcCtD
Carbimazole—Skin disorder—Azathioprine—multiple sclerosis	0.000999	0.00398	CcSEcCtD
Carbimazole—Haemoglobin—Prednisolone—multiple sclerosis	0.000965	0.00385	CcSEcCtD
Carbimazole—Haemorrhage—Prednisolone—multiple sclerosis	0.00096	0.00383	CcSEcCtD
Carbimazole—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000945	0.00377	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000937	0.00373	CcSEcCtD
Carbimazole—Hypersensitivity—Cladribine—multiple sclerosis	0.000932	0.00371	CcSEcCtD
Carbimazole—Malaise—Mitoxantrone—multiple sclerosis	0.000919	0.00366	CcSEcCtD
Carbimazole—Leukopenia—Mitoxantrone—multiple sclerosis	0.000912	0.00363	CcSEcCtD
Carbimazole—Pruritus—Cladribine—multiple sclerosis	0.000895	0.00357	CcSEcCtD
Carbimazole—Haemoglobin—Triamcinolone—multiple sclerosis	0.000887	0.00354	CcSEcCtD
Carbimazole—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000885	0.00353	CcSEcCtD
Carbimazole—Haemorrhage—Triamcinolone—multiple sclerosis	0.000883	0.00352	CcSEcCtD
Carbimazole—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000881	0.00351	CcSEcCtD
Carbimazole—Myalgia—Mitoxantrone—multiple sclerosis	0.000867	0.00346	CcSEcCtD
Carbimazole—Arthralgia—Mitoxantrone—multiple sclerosis	0.000867	0.00346	CcSEcCtD
Carbimazole—Discomfort—Mitoxantrone—multiple sclerosis	0.000857	0.00342	CcSEcCtD
Carbimazole—Feeling abnormal—Azathioprine—multiple sclerosis	0.000847	0.00338	CcSEcCtD
Carbimazole—Infection—Mitoxantrone—multiple sclerosis	0.000826	0.00329	CcSEcCtD
Carbimazole—Neutropenia—Prednisone—multiple sclerosis	0.000815	0.00325	CcSEcCtD
Carbimazole—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000814	0.00324	CcSEcCtD
Carbimazole—Body temperature increased—Azathioprine—multiple sclerosis	0.000813	0.00324	CcSEcCtD
Carbimazole—Skin disorder—Mitoxantrone—multiple sclerosis	0.000807	0.00322	CcSEcCtD
Carbimazole—Haemoglobin—Betamethasone—multiple sclerosis	0.000805	0.00321	CcSEcCtD
Carbimazole—Haemoglobin—Dexamethasone—multiple sclerosis	0.000805	0.00321	CcSEcCtD
Carbimazole—Haemorrhage—Dexamethasone—multiple sclerosis	0.000801	0.00319	CcSEcCtD
Carbimazole—Haemorrhage—Betamethasone—multiple sclerosis	0.000801	0.00319	CcSEcCtD
Carbimazole—Angiopathy—Methylprednisolone—multiple sclerosis	0.000799	0.00319	CcSEcCtD
Carbimazole—Rash—Cladribine—multiple sclerosis	0.000797	0.00318	CcSEcCtD
Carbimazole—Dermatitis—Cladribine—multiple sclerosis	0.000797	0.00318	CcSEcCtD
Carbimazole—Headache—Cladribine—multiple sclerosis	0.000792	0.00316	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000778	0.0031	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000775	0.00309	CcSEcCtD
Carbimazole—Angioedema—Prednisolone—multiple sclerosis	0.000764	0.00304	CcSEcCtD
Carbimazole—Hypersensitivity—Azathioprine—multiple sclerosis	0.000758	0.00302	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000757	0.00302	CcSEcCtD
Carbimazole—Malaise—Prednisolone—multiple sclerosis	0.000754	0.003	CcSEcCtD
Carbimazole—Nausea—Cladribine—multiple sclerosis	0.000751	0.00299	CcSEcCtD
Carbimazole—Angiopathy—Betamethasone—multiple sclerosis	0.000727	0.0029	CcSEcCtD
Carbimazole—Angiopathy—Dexamethasone—multiple sclerosis	0.000727	0.0029	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—multiple sclerosis	0.000721	0.00287	CcSEcCtD
Carbimazole—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000713	0.00284	CcSEcCtD
Carbimazole—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000711	0.00284	CcSEcCtD
Carbimazole—Alopecia—Dexamethasone—multiple sclerosis	0.000708	0.00282	CcSEcCtD
Carbimazole—Alopecia—Betamethasone—multiple sclerosis	0.000708	0.00282	CcSEcCtD
Carbimazole—Discomfort—Prednisolone—multiple sclerosis	0.000703	0.0028	CcSEcCtD
Carbimazole—Angioedema—Triamcinolone—multiple sclerosis	0.000702	0.0028	CcSEcCtD
Carbimazole—Haemoglobin—Prednisone—multiple sclerosis	0.000701	0.00279	CcSEcCtD
Carbimazole—Angioedema—Methylprednisolone—multiple sclerosis	0.000701	0.00279	CcSEcCtD
Carbimazole—Haemorrhage—Prednisone—multiple sclerosis	0.000698	0.00278	CcSEcCtD
Carbimazole—Malaise—Triamcinolone—multiple sclerosis	0.000693	0.00276	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—multiple sclerosis	0.000692	0.00276	CcSEcCtD
Carbimazole—Malaise—Methylprednisolone—multiple sclerosis	0.000691	0.00276	CcSEcCtD
Carbimazole—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000685	0.00273	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—multiple sclerosis	0.000681	0.00271	CcSEcCtD
Carbimazole—Urticaria—Mitoxantrone—multiple sclerosis	0.00066	0.00263	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.000657	0.0888	CbGpPWpGaD
Carbimazole—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000657	0.00262	CcSEcCtD
Carbimazole—Myalgia—Triamcinolone—multiple sclerosis	0.000654	0.00261	CcSEcCtD
Carbimazole—Arthralgia—Methylprednisolone—multiple sclerosis	0.000653	0.0026	CcSEcCtD
Carbimazole—Myalgia—Methylprednisolone—multiple sclerosis	0.000653	0.0026	CcSEcCtD
Carbimazole—Rash—Azathioprine—multiple sclerosis	0.000648	0.00258	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000648	0.00258	CcSEcCtD
Carbimazole—Dermatitis—Azathioprine—multiple sclerosis	0.000648	0.00258	CcSEcCtD
Carbimazole—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000647	0.00258	CcSEcCtD
Carbimazole—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000647	0.00258	CcSEcCtD
Carbimazole—Discomfort—Triamcinolone—multiple sclerosis	0.000646	0.00258	CcSEcCtD
Carbimazole—Discomfort—Methylprednisolone—multiple sclerosis	0.000645	0.00257	CcSEcCtD
Carbimazole—Headache—Azathioprine—multiple sclerosis	0.000644	0.00257	CcSEcCtD
Carbimazole—Angioedema—Betamethasone—multiple sclerosis	0.000637	0.00254	CcSEcCtD
Carbimazole—Angioedema—Dexamethasone—multiple sclerosis	0.000637	0.00254	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—multiple sclerosis	0.000633	0.00252	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—multiple sclerosis	0.000633	0.00252	CcSEcCtD
Carbimazole—Malaise—Dexamethasone—multiple sclerosis	0.000629	0.00251	CcSEcCtD
Carbimazole—Malaise—Betamethasone—multiple sclerosis	0.000629	0.00251	CcSEcCtD
Carbimazole—Infection—Triamcinolone—multiple sclerosis	0.000623	0.00248	CcSEcCtD
Carbimazole—Infection—Methylprednisolone—multiple sclerosis	0.000622	0.00248	CcSEcCtD
Carbimazole—Alopecia—Prednisone—multiple sclerosis	0.000616	0.00246	CcSEcCtD
Carbimazole—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000614	0.00245	CcSEcCtD
Carbimazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000612	0.00244	CcSEcCtD
Carbimazole—Nausea—Azathioprine—multiple sclerosis	0.000611	0.00243	CcSEcCtD
Carbimazole—Skin disorder—Methylprednisolone—multiple sclerosis	0.000608	0.00242	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—multiple sclerosis	0.000606	0.00242	CcSEcCtD
Carbimazole—Myalgia—Dexamethasone—multiple sclerosis	0.000594	0.00237	CcSEcCtD
Carbimazole—Myalgia—Betamethasone—multiple sclerosis	0.000594	0.00237	CcSEcCtD
Carbimazole—Discomfort—Betamethasone—multiple sclerosis	0.000587	0.00234	CcSEcCtD
Carbimazole—Discomfort—Dexamethasone—multiple sclerosis	0.000587	0.00234	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—multiple sclerosis	0.000586	0.00234	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—multiple sclerosis	0.000583	0.00232	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—multiple sclerosis	0.000583	0.00232	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000571	0.00228	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00057	0.00227	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.000568	0.0767	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.000568	0.0767	CbGpPWpGaD
Carbimazole—Infection—Betamethasone—multiple sclerosis	0.000565	0.00225	CcSEcCtD
Carbimazole—Infection—Dexamethasone—multiple sclerosis	0.000565	0.00225	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000563	0.00225	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000562	0.00224	CcSEcCtD
Carbimazole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000558	0.00222	CcSEcCtD
Carbimazole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000558	0.00222	CcSEcCtD
Carbimazole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000557	0.00222	CcSEcCtD
Carbimazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000557	0.00222	CcSEcCtD
Carbimazole—Angioedema—Prednisone—multiple sclerosis	0.000555	0.00221	CcSEcCtD
Carbimazole—Malaise—Prednisone—multiple sclerosis	0.000548	0.00218	CcSEcCtD
Carbimazole—Urticaria—Prednisolone—multiple sclerosis	0.000542	0.00216	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—multiple sclerosis	0.000529	0.00211	CcSEcCtD
Carbimazole—Rash—Mitoxantrone—multiple sclerosis	0.000524	0.00209	CcSEcCtD
Carbimazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.000524	0.00209	CcSEcCtD
Carbimazole—Headache—Mitoxantrone—multiple sclerosis	0.000521	0.00208	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000518	0.00207	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000518	0.00207	CcSEcCtD
Carbimazole—Myalgia—Prednisone—multiple sclerosis	0.000517	0.00206	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—multiple sclerosis	0.000517	0.00206	CcSEcCtD
Carbimazole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000517	0.00206	CcSEcCtD
Carbimazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000516	0.00206	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—multiple sclerosis	0.000515	0.00205	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000513	0.00205	CcSEcCtD
Carbimazole—Discomfort—Prednisone—multiple sclerosis	0.000511	0.00204	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000502	0.002	CcSEcCtD
Carbimazole—Urticaria—Triamcinolone—multiple sclerosis	0.000498	0.00199	CcSEcCtD
Carbimazole—Urticaria—Methylprednisolone—multiple sclerosis	0.000497	0.00198	CcSEcCtD
Carbimazole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000496	0.00198	CcSEcCtD
Carbimazole—Nausea—Mitoxantrone—multiple sclerosis	0.000494	0.00197	CcSEcCtD
Carbimazole—Infection—Prednisone—multiple sclerosis	0.000492	0.00196	CcSEcCtD
Carbimazole—Nervous system disorder—Prednisone—multiple sclerosis	0.000486	0.00194	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—multiple sclerosis	0.000481	0.00192	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000471	0.00188	CcSEcCtD
Carbimazole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000469	0.00187	CcSEcCtD
Carbimazole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000469	0.00187	CcSEcCtD
Carbimazole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000462	0.00184	CcSEcCtD
Carbimazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000461	0.00184	CcSEcCtD
Carbimazole—Malaise—Methotrexate—multiple sclerosis	0.000458	0.00182	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—multiple sclerosis	0.000454	0.00181	CcSEcCtD
Carbimazole—Urticaria—Dexamethasone—multiple sclerosis	0.000452	0.0018	CcSEcCtD
Carbimazole—Urticaria—Betamethasone—multiple sclerosis	0.000452	0.0018	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000452	0.0018	CcSEcCtD
Carbimazole—Body temperature increased—Dexamethasone—multiple sclerosis	0.00045	0.00179	CcSEcCtD
Carbimazole—Body temperature increased—Betamethasone—multiple sclerosis	0.00045	0.00179	CcSEcCtD
Carbimazole—Pruritus—Triamcinolone—multiple sclerosis	0.000444	0.00177	CcSEcCtD
Carbimazole—Pruritus—Methylprednisolone—multiple sclerosis	0.000443	0.00176	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—multiple sclerosis	0.000432	0.00172	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—multiple sclerosis	0.000432	0.00172	CcSEcCtD
Carbimazole—Rash—Prednisolone—multiple sclerosis	0.00043	0.00171	CcSEcCtD
Carbimazole—Dermatitis—Prednisolone—multiple sclerosis	0.00043	0.00171	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000429	0.00171	CcSEcCtD
Carbimazole—Headache—Prednisolone—multiple sclerosis	0.000427	0.0017	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—multiple sclerosis	0.000427	0.0017	CcSEcCtD
Carbimazole—Infection—Methotrexate—multiple sclerosis	0.000411	0.00164	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisone—multiple sclerosis	0.000408	0.00163	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—multiple sclerosis	0.000406	0.00162	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000406	0.00162	CcSEcCtD
Carbimazole—Nausea—Prednisolone—multiple sclerosis	0.000405	0.00161	CcSEcCtD
Carbimazole—Pruritus—Betamethasone—multiple sclerosis	0.000403	0.0016	CcSEcCtD
Carbimazole—Pruritus—Dexamethasone—multiple sclerosis	0.000403	0.0016	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—multiple sclerosis	0.000402	0.0016	CcSEcCtD
Carbimazole—Rash—Triamcinolone—multiple sclerosis	0.000395	0.00158	CcSEcCtD
Carbimazole—Dermatitis—Triamcinolone—multiple sclerosis	0.000395	0.00157	CcSEcCtD
Carbimazole—Rash—Methylprednisolone—multiple sclerosis	0.000395	0.00157	CcSEcCtD
Carbimazole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000394	0.00157	CcSEcCtD
Carbimazole—Urticaria—Prednisone—multiple sclerosis	0.000394	0.00157	CcSEcCtD
Carbimazole—Headache—Triamcinolone—multiple sclerosis	0.000393	0.00157	CcSEcCtD
Carbimazole—Headache—Methylprednisolone—multiple sclerosis	0.000392	0.00156	CcSEcCtD
Carbimazole—Body temperature increased—Prednisone—multiple sclerosis	0.000392	0.00156	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000377	0.0015	CcSEcCtD
Carbimazole—Nausea—Triamcinolone—multiple sclerosis	0.000373	0.00148	CcSEcCtD
Carbimazole—Nausea—Methylprednisolone—multiple sclerosis	0.000372	0.00148	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisone—multiple sclerosis	0.000365	0.00146	CcSEcCtD
Carbimazole—Rash—Dexamethasone—multiple sclerosis	0.000359	0.00143	CcSEcCtD
Carbimazole—Rash—Betamethasone—multiple sclerosis	0.000359	0.00143	CcSEcCtD
Carbimazole—Dermatitis—Betamethasone—multiple sclerosis	0.000358	0.00143	CcSEcCtD
Carbimazole—Dermatitis—Dexamethasone—multiple sclerosis	0.000358	0.00143	CcSEcCtD
Carbimazole—Headache—Betamethasone—multiple sclerosis	0.000357	0.00142	CcSEcCtD
Carbimazole—Headache—Dexamethasone—multiple sclerosis	0.000357	0.00142	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000352	0.0475	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000352	0.0475	CbGpPWpGaD
Carbimazole—Pruritus—Prednisone—multiple sclerosis	0.000351	0.0014	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000347	0.0469	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000347	0.0469	CbGpPWpGaD
Carbimazole—Feeling abnormal—Methotrexate—multiple sclerosis	0.000341	0.00136	CcSEcCtD
Carbimazole—Nausea—Betamethasone—multiple sclerosis	0.000338	0.00135	CcSEcCtD
Carbimazole—Nausea—Dexamethasone—multiple sclerosis	0.000338	0.00135	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—multiple sclerosis	0.000329	0.00131	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—multiple sclerosis	0.000327	0.00131	CcSEcCtD
Carbimazole—Rash—Prednisone—multiple sclerosis	0.000312	0.00125	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—multiple sclerosis	0.000312	0.00124	CcSEcCtD
Carbimazole—Headache—Prednisone—multiple sclerosis	0.00031	0.00124	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—multiple sclerosis	0.000305	0.00122	CcSEcCtD
Carbimazole—Nausea—Prednisone—multiple sclerosis	0.000294	0.00117	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—multiple sclerosis	0.000293	0.00117	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000285	0.0385	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000285	0.0385	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000273	0.0368	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.000267	0.036	CbGpPWpGaD
Carbimazole—Rash—Methotrexate—multiple sclerosis	0.000261	0.00104	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—multiple sclerosis	0.000261	0.00104	CcSEcCtD
Carbimazole—Headache—Methotrexate—multiple sclerosis	0.000259	0.00103	CcSEcCtD
Carbimazole—Nausea—Methotrexate—multiple sclerosis	0.000246	0.000981	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000222	0.03	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.00019	0.0257	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TGFB1—multiple sclerosis	0.000179	0.0242	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000171	0.023	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.000156	0.0211	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000152	0.0205	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000152	0.0205	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00015	0.0202	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00015	0.0202	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000143	0.0193	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6—multiple sclerosis	0.000135	0.0182	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000128	0.0172	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SRM—multiple sclerosis	0.000121	0.0163	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP27B1—multiple sclerosis	8.51e-05	0.0115	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP24A1—multiple sclerosis	8.51e-05	0.0115	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	8.48e-05	0.0115	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.92e-05	0.0107	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPC5—multiple sclerosis	7.78e-05	0.0105	CbGpPWpGaD
Carbimazole—TPO—Metabolism—RRM1—multiple sclerosis	6.45e-05	0.0087	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.42e-05	0.00867	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.82e-05	0.00786	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.82e-05	0.00786	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BCHE—multiple sclerosis	3.7e-05	0.005	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SRM—multiple sclerosis	3.68e-05	0.00497	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.0046	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.0035	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.0035	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.53e-05	0.00342	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.0032	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—multiple sclerosis	2.23e-05	0.00301	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.19e-05	0.00295	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.14e-05	0.00289	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RRM1—multiple sclerosis	1.96e-05	0.00265	CbGpPWpGaD
Carbimazole—TPO—Metabolism—POMC—multiple sclerosis	1.91e-05	0.00258	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—multiple sclerosis	1.74e-05	0.00236	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.52e-05	0.00206	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	0.00177	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.19e-05	0.00161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.00152	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—multiple sclerosis	6.79e-06	0.000917	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—POMC—multiple sclerosis	5.83e-06	0.000787	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—multiple sclerosis	5.32e-06	0.000718	CbGpPWpGaD
